Prostate News and Research

RSS

State-of-the-art laparoscopic robotic technology sends most prostate patients home the day after surgery

As recently as three years ago, the gold standard to treat prostate cancer, the second most common form of cancer in men, was an invasive surgery that required up to a one-week hospital stay.

2 Aug 2004

New approach to cancer vaccines may eradicate skin cancer tumors

Mayo Clinic and British researchers have developed a new approach to cancer vaccines that purposely kills healthy skin cells to target the immune system against tumors. The new approach has eradicated skin cancer tumors in mice.

2 Aug 2004

Cancer detection kit, which fuses molecular diagnostics with nanotechnology

Acrongenomics Inc. has introduced a revolutionary design of its nanobiotechnology product, the Neo-EpCAM(TM) cancer detection kit, which fuses molecular diagnostics with nanotechnology.

29 Jul 2004

Combination of hormonal therapy, radioactive seed implant and external beam radiation therapy increases chance of cancer cure

High-risk prostate cancer patients who undergo a combination of hormonal therapy, radioactive seed implant (also called brachytherapy) and external beam radiation therapy are shown to have an increased chance of cancer cure

29 Jul 2004

Further evidence about how estrogen helps activate breast cancer

A UC Irvine researcher has found a novel tumor- suppressor function for a gene that, when mutated, often triggers breast cancer in women.

29 Jul 2004

Women with a history of cancer in their family are better off having MRI scans instead of mammograms

New research by Mieke Kriege at the Department of Medical Oncology, Rotterdam Family Cancer Clinic suggests that women with a history of cancer in their family are better off having MRI scans instead of mammogram's.

28 Jul 2004

CancerVax may increase the survival of patients with advanced stage non-small-cell lung cancer

CancerVax Corporation has announced that its wholly owned subsidiaries, Tarcanta, Inc., and Tarcanta, Ltd. (Ireland), have obtained the exclusive rights to complete the clinical development of three specific active immunotherapeutic (SAI) product candidates that target the epidermal growth factor receptor (EGFR) signaling pathway for the treatment of cancer.

19 Jul 2004

Stat5 protein is particularly plentiful in high histological grade human prostate cancer

Prostate cancer is much more likely to be aggressive if a key protein called Stat5 is found activated and in abundance in the cancer cells, report researchers from Georgetown University's Lombardi Comprehensive Cancer Center.

15 Jul 2004

Research may help predict risk for prostate cancer based on gene expression patterns

According to a study published in the July 15 issue of the Journal of Clinical Oncology, genes expressed in benign tissue adjacent to prostate cancer tissue are much more similar to those expressed in prostate cancer tissue than previously thought.

15 Jul 2004

Today's prostate cancer treatments are more aggressive and successful

In recent years, doctors have become more willing to treat prostate cancer more aggressively with radiation therapy, and as a result, more patients are being cured of their cancer

15 Jul 2004

Educating patients can help limit side effects of chemotherapy and radiation

A new study finds patients about to undergo chemotherapy or radiation expect a high number of side effects, and that age, gender, educational background, and the type of cancer all influence how many side effects a patient expects.

12 Jul 2004

Pfizer focuses on enabling America's 43 million uninsured to obtain medicines at significant savings

Pfizer Inc said today it will launch the pharmaceutical industry's most comprehensive initiative to significantly expand access to prescription medicines across the United States, with a specific focus on enabling America's 43 million uninsured to obtain Pfizer medicines at significant savings.

7 Jul 2004

New compound, ZK-CDK combines the inhibition of tumour cell growth as well as inhibition of tumour angiogenesis in one single molecule

Treatment with a new dual cell cycle and angiogenesis pathway inhibitor blocks VEGF-induced vascular permeability, inhibits tumour angiogenesis and induces apoptosis in human tumour models

7 Jul 2004

British people should get out in the sun and not cover up for health reasons

British health is being put at risk by government policy that discourages sunbathing and promotes use of sunblock products. The cost of disease caused by insufficient exposure to sunlight and consequent deficiency of vitamin D is estimated to be billions of pounds per year in Britain.

5 Jul 2004

TUNA therapy results in significantly reduced erectile dysfunction

Comparing five-year results of Medtronic TUNA® Therapy (transurethral needle ablation) to surgery for 121 men in their mid-60s with lower urinary tract symptoms caused by an enlarged prostate, a team of urologists found that “for appropriately selected patients with bothersome voiding symptoms, TUNA is an attractive treatment option.”

1 Jul 2004

Four most common cancers accounted for over half of the 225,000 new cases of malignant cancer registered in England in 2001

The four most common cancers - breast, lung, colorectal and prostate - accounted for over half of the 225,000 new cases of malignant cancer (excluding non-melanoma skin cancer) registered in England in 2001.

30 Jun 2004

Men can live a long time after treatment for prostate cancer, and they deserve to have a good quality of life

As many prostate-cancer survivors have discovered, the lifesaving benefits of surgery, radiation and hormone therapy can come with a cost.

29 Jun 2004

New study could bring hope to men who don't respond well to hormone therapy for prostate cancer

More than 1 million American have prostate cancer, the leading non-skin cancer in men in the United States. Last year alone some 220,000 new prostate cancer cases were reported, and 28,900 men died of it.

25 Jun 2004

There are 9.8 million cancer survivors in the United States

A cancer survivor is defined as anyone who has been diagnosed with cancer, from the time of diagnosis through the balance of his or her life. The findings are published in the June 25 issue of CDC's Morbidity and Mortality Weekly Report, "Cancer Survivorship - United States, 1971 - 2001."

24 Jun 2004

Prostate and kidney cancer can be detected in urine

Bladder cancer is the fourth most common male cancer in the Western world. There will be more than 44,6000 new cases of bladder cancer diagnosed in U.S. men this year and more than 15,600 new cases diagnosed in women As many as 25 percent of these cancers are diagnosed after the disease is advanced, leading to a poor prognosis.

23 Jun 2004

Prostate News and Research

State-of-the-art laparoscopic robotic technology sends most prostate patients home the day after surgery

New approach to cancer vaccines may eradicate skin cancer tumors

Cancer detection kit, which fuses molecular diagnostics with nanotechnology

Combination of hormonal therapy, radioactive seed implant and external beam radiation therapy increases chance of cancer cure

Further evidence about how estrogen helps activate breast cancer

Women with a history of cancer in their family are better off having MRI scans instead of mammograms

CancerVax may increase the survival of patients with advanced stage non-small-cell lung cancer

Stat5 protein is particularly plentiful in high histological grade human prostate cancer

Research may help predict risk for prostate cancer based on gene expression patterns

Today's prostate cancer treatments are more aggressive and successful

Educating patients can help limit side effects of chemotherapy and radiation

Pfizer focuses on enabling America's 43 million uninsured to obtain medicines at significant savings

New compound, ZK-CDK combines the inhibition of tumour cell growth as well as inhibition of tumour angiogenesis in one single molecule

British people should get out in the sun and not cover up for health reasons

TUNA therapy results in significantly reduced erectile dysfunction

Four most common cancers accounted for over half of the 225,000 new cases of malignant cancer registered in England in 2001

Men can live a long time after treatment for prostate cancer, and they deserve to have a good quality of life

New study could bring hope to men who don't respond well to hormone therapy for prostate cancer

There are 9.8 million cancer survivors in the United States

Prostate and kidney cancer can be detected in urine

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News